Ligand validation:2A2Z

DCZ: 2'-DEOXYCYTIDINE

DCZ is a Ligand Of Interest in 2A2Z designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
2A2Z_DCZ_A_304	58%	18%	0.173	0.953	1.55	1.96	2	7	0	0	100%	1
2A2Z_DCZ_D_604	55%	17%	0.187	0.958	1.66	1.95	2	5	0	0	100%	1
2A2Z_DCZ_C_504	46%	21%	0.218	0.956	1.57	1.76	2	6	0	0	100%	1
2A2Z_DCZ_B_404	38%	18%	0.237	0.942	1.67	1.85	3	7	0	0	100%	1
2A30_DCZ_B_402	64%	19%	0.169	0.967	1.52	1.91	3	5	1	0	100%	1
5FBD_DCZ_A_701	85%	74%	0.08	0.945	0.52	0.5	-	-	0	0	100%	1
5FBG_DCZ_A_701	84%	73%	0.087	0.947	0.42	0.62	-	-	0	0	100%	1
1P61_DCZ_B_302	83%	17%	0.104	0.964	2.26	1.35	5	3	0	0	100%	1
2NO1_DCZ_B_302	78%	11%	0.133	0.975	2.56	1.65	5	7	1	0	100%	1
9F09_DCZ_A_201	71%	36%	0.106	0.927	0.87	1.62	1	6	1	0	100%	0.94

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.